At ECRIN we can provide support to investigators for the preparation of calls for multinational clinical trial funding, provided that the projects are funded and meet the ECRIN eligibility criteria.
For more information on how ECRIN can support you in the preparation of these calls, see Clinical Trials Preparation and contact your local European Correspondent.
The calls listed below may be relevant for your applications for clinical trials / clinical research in various fields. In the News section of our website, you can also find additional information on calls on diverse topics other than clinical trials.
Discover the European funding programs for multinational clinical trials and specific calls for COVID19 Clinical Research.
Call Launch :
Deadline 2 :
Five European anti-cancer charities (Fundación científica Asociación Española Contra el Cáncer (Spain); The Anticancer Fund (Belgium); Fondation ARC (France); Kom op tegen Kanker (Belgium); Dutch Cancer Society (The Netherlands)) are joining forces to stimulate international research on rare cancer drug development. The focus of this joint international call, the ATTRACT-Call, is on late phase (2/3) clinical trials on rare cancer drugs. Improving treatment for rare cancers as well as bringing drug development to the next developmental stage are two of the current target goals.
All information regarding the ATTRACT-call, including background, scope, application requirements, preferences and recommendations, review procedure, timelines, funding conditions and estimated budgets can be found in the Guidelines for Applicants (available on KWF website)
Call Launch :
Digital technologies in mental health care, advanced therapies for rare diseases, and improving hospital care are among the topics pencilled in for IHI’s next calls for proposals.
IHI has published the draft texts of topics under consideration for inclusion in the next calls for proposals on the Future Opportunities page of the website.
Concerning IHI 4, a two stage call:
- Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical drug safety assessment
- Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare
IHI is publishing the draft topic texts in advance of the official call launch to give potential applicants additional time to start building a consortium and drafting a proposal.
- Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment
- Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare
Note that the topics may change considerably between the versions published here and the call launch, and applicants should check the final, approved topic texts once the calls are launched.
Important note: All information regarding future IHI call topics is indicative and subject to change. Final information about future IHI calls will be communicated after approval by the IHI Governing Board.